fda shortage semaglutide injection resolved feb 21 2025 📢 has determined the of products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the End of Semaglutide Shortage Means

Chen Z-R, Hong Y, Wen S-H, Zhan Y-Q, Huang W-Q

A study found that aerobic endurance training led to a drop in lead levels, with rowing more effective than cycling, but how long and how intense did the workout need to be

CrossRef Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study Jung Sun Kim, Jeffrey Wong, SanChi Chen, David Tai, Hannah Yang, Youngun Kim, Beodeul Kang, Ilhwan Kim, Hyeyeong Kim, Chansik An, Su Jin Jang, Masatoshi Kudo, Ho Yeong Lim, Chan Kim, Thomas Yau, Hong Jae Chon Liver International .2026;[Epub] CrossRef Integrative analyses of network pharmacology and bioinformatics reveal the synergistic antitumor effects of cantharidin and ginsenosides Rg3 on hepatocellular carcinoma Xianggang Gou, Zhongzheng Zhou, Yuehua Wang, Henye Yuan, Ziyao Wang, Jie Chen, Wei Yan, Haisheng Wang, Jia Yan Biochemical Pharmacology .2026

CTS is not necessarily a permanent condition